Advanced Catheter Therapies
3 known investors
Advanced Catheter Therapies develops the Pressana Occlusion Perfusion Catheter, a medical device for targeted endovascular delivery of therapeutic agents to treat peripheral arterial disease and prevent limb amputation. The device is FDA-cleared for below-the-knee use and enables localized infusion of various physician-prescribed medications to prevent restenosis after vessel modification procedures.
Founders & leadership
PJ
Paul J. FitzpatrickChief Executive Officer
Investors · 3
Competitors · 5
by search overlapBoston Scientific12 shared keywordsBoston Scientific supports external researcher-initiated studies through its Investigator Sponsored Research program, which funds independent investigations addressing disease understanding and treatment gaps of interest to the medical community.
Read the Press Release8 shared keywordsStryker is a medical technology company that develops and manufactures products across areas such as orthopaedics, surgical equipment, neurotechnology, and spine care for hospitals and healthcare providers. It operates globally across the Americas, Europe, Asia-Pacific, and the Middle East.
Merit Medical7 shared keywordsMerit Medical Systems designs, develops, manufactures and markets medical devices for interventional and diagnostic procedures. The company serves healthcare providers and clinical practitioners in the medical device industry.
Rf Surgical7 shared keywordsMedtronic is a healthcare technology company that develops medical devices and technologies — including pacemakers, robotic-assisted surgery systems, and AI-driven health tools — used by doctors, scientists, and engineers to treat pain and disease. It works with clinicians to create solutions aimed at treating conditions such as AFib.
AngioDynamics6 shared keywordsAngioDynamics develops and manufactures medical devices aimed at treating serious diseases and improving patient outcomes. Founded in 1988, the company serves healthcare professionals and operates globally across North America, Europe, the Middle East, and South America.
Companies competing with Advanced Catheter Therapies for the same Google search keywords, organic and paid, via search-intersection analysis.
Frequently asked questions
- What does Advanced Catheter Therapies do?
- Advanced Catheter Therapies develops the Pressana Occlusion Perfusion Catheter, a medical device for targeted endovascular delivery of therapeutic agents to treat peripheral arterial disease and prevent limb amputation. The device is FDA-cleared for below-the-knee use and enables localized infusion of various physician-prescribed medications to prevent restenosis after vessel modification procedures.
- Who are Advanced Catheter Therapies's investors?
- Advanced Catheter Therapies's investors include Chattanooga Renaissance Fund, Innova Memphis, Inc., Solas BioVentures.